Ibutamoren

From WikiMD.org
Jump to navigation Jump to search

Ibutamoren

Ibutamoren (pronounced: i-bu-ta-mo-ren), also known as MK-677, is a non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue. It is an investigational new drug developed for the treatment of conditions such as growth hormone deficiency and osteoporosis.

Etymology

The term "Ibutamoren" is derived from the combination of chemical elements present in the drug. The prefix "Ibu-" is derived from the chemical element Iodine (I), the middle "-tam-" is derived from the chemical element Tantalum (Ta), and the suffix "-oren" is derived from the chemical element Oxygen (O) and Rhenium (Re).

Usage

Ibutamoren is used to stimulate the production of growth hormone and insulin-like growth factor 1 (IGF-1) without affecting the levels of other hormones such as cortisol. It is also used in the treatment of muscle wasting associated with conditions such as HIV and cancer.

Side Effects

Potential side effects of Ibutamoren include increased appetite, mild lower extremity edema, and muscle pain. Long-term use may lead to increased risk of diabetes and changes in lipid metabolism.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski